Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
Cited in blog · New England Journal of Medicine. · 2023
Lincoff AM, et al. (2023). *Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes*. New England Journal of Medicine.
Authors
Lincoff AM, et al.
Research lens
Lincoff AM, et al. (2023). *Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes*. New England Journal of Medicine.
- blog
- tracking-state-without-making-clients-perform-insight-2026-07-12